NEW YORK ( TheStreet) -- C.R. Bard (NYSE: BCR) hit a new 52-week high Wednesday as it is currently trading at $111.70, above its previous 52-week high of $110.86 with 94,192 shares traded as of 10:16 a.m. ET. Average volume has been 677,100 shares over the past 30 days.

C.R. Bard has a market cap of $9.4 billion and is part of the health care sector and health services industry. Shares are up 20.6% year to date as of the close of trading on Tuesday.

C. R. Bard, Inc., together with its subsidiaries, engages in the design, manufacture, packaging, distribution, and sale of medical, surgical, diagnostic, and patient care devices worldwide. It offers vascular, urology, oncology, and surgical specialty products. The company has a P/E ratio of 19.6, equal to the average health services industry P/E ratio and above the S&P 500 P/E ratio of 17.7.
  • Practice your BCR trading strategies and win cash in our stock game.

TheStreet Ratings rates C.R. Bard as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, impressive record of earnings per share growth, notable return on equity and expanding profit margins. We feel these strengths outweigh the fact that the company shows weak operating cash flow. You can view the full C.R. Bard Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.